Global Top 6 Infectious DiseaseTherapeutics Market is
expected to reach USD 86.2 billion by 2025, according to a new report by
Grand View Research, Inc. The market is primarily driven by increasing number
of Human Immunodeficiency Virus (HIV), Human Papillomavirus (HPV), TB, and
hepatitis cases globally.
Government and private organizations are
investing heavily in the healthcare sector to prevent, diagnose, and treat
infectious diseases; rising investments for development of new drugs to treat
infectious diseases, and increasing number of initiatives for creating
awareness about these conditions are expected to boost the market during the
forecast period. Furthermore, increasing number of patent expirations and entry
of generic drugs in the market are expected to increase the demand for
infectious disease therapeutics due to their low prices.
In addition, availability of reimbursement
for diagnosis & treatment of these infections and free distribution of drugs
by manufacturers in regions with high incidence of these diseases are factors
further expected to propel the market growth. However, low penetration rate of
anti-infective and availability of large number of counterfeit drugs are
expected to restraint the market growth during the forecast period.
North American market held the largest
share in 2016. Presence of large number of manufacturers, favorable
reimbursement scenario, and increasing healthcare expenditure are major factors
responsible for the largest share held by this region. However, Asia Pacific is
likely to grow at the highest rate between 2017 and 2025. High prevalence of
infectious diseases; improving economic conditions in Asian countries, rising
government initiatives to increase the adoption of treatments for infectious
diseases, and rising funding activities are factors that can be attributed for
the highest growth rate of this region during the forecast period.
Full Research Report On Global Infectious
Disease Therapeutics Market Analysis:
http://www.grandviewresearch.com/industry-analysis/infectious-disease-therapeutics-market
http://www.grandviewresearch.com/industry-analysis/infectious-disease-therapeutics-market
Further Key Findings From the Report
Suggest:
- The HIV therapeutics segment held the largest revenue share in
2016 due to high number of HIV cases globally
- North America dominated the global market owing to the strong
reimbursement framework coupled with high adoption rate of treatments for
infectious diseases
- The HPV therapeutics segment is estimated to grow at the
highest rate during the forecast period
- Some of the key players areNovartis AG, Gilead, GlaxoSmithKline
plc, Janssen Pharmaceutical, Inc., F. Hoffmann-La Roche Ltd., BioCryst
Pharmaceuticals, Inc., and Boehringer Ingelheim GmbH
View
more reports of this category by Grand View Research at: http://www.grandviewresearch.com/industry/medical-devices
Grand
View Research has segmented the Top 6 Infectious Disease Therapeutics Market on
the basis of disease type and region:
Disease Type Outlook (Revenue, USD
Million, 2014 - 2025)
- HIV
- Emtriva
- Aptivus
- Isentress
- Lexiva/Telzir
- Selzentry
- Tivicay
- Atripla
- Complera
- Genvoya
- Odefsey
- Stribild
- Truvada
- Triumeq
- Descovy
- Vitekta
- Others
- Influenza
- Relenza
- Tamiflu
- Rapivab
- Others
- TB
- Sirturo
- Others
- Malaria
- Coartem
- Others
- HPV
- Hepatitis
Regional Outlook (Revenue, USD Million,
2014 - 2025)
- North America
- U.S.
- Canada
- Europe
- Germany
- UK
- Asia Pacific
- China
- Japan
- Latin America
- Brazil
- Mexico
- Middle East & Africa
- South Africa
View Press Release Of This Report by
Grand View Research: http://www.grandviewresearch.com/press-release/global-infectious-disease-therapeutics-market
About Grand View
Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.
For more Information visit: www.grandviewresearch.com
No comments:
Post a Comment